01 1Ajinomoto Company
01 1LEVODOPA
01 1Japan
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-08-17
Pay. Date : 2017-07-18
DMF Number : 12379
Submission : 1997-02-19
Status : Active
Type : II
20
Ajinomoto Co Inc, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LEVODOPA, with a corresponding US DMF Number 12379.
Remarkably, this DMF maintains an Active status since its submission on February 19, 1997, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 17, 2017, and payment made on July 18, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
